FDA Targets Anti-Diarrhea Treatment In Campaign To Curb Overdoses From Over-The-Counter Drugs

The Food and Drug Administration has asked the manufacturers of anti-diarrhea treatment to package the product differently to make it harder for the drug to be abused. The key ingredient in anti-diarrhea medications like Imodium is part of the opioid family. In other news, a pain medication with a checkered past may offer an alternative to opioids, Attorney General Jeff Sessions says the Drug Enforcement Administration is planning on targeting pharmacies as part of its crack down efforts, Congress tries to tackle the issue, and more.

from Kaiser Health News http://ift.tt/2DOjbW5